Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Beneficial Effects of Exclusive Enteral Nutrition in Crohn's Disease Are not Mediated by Faecalibacterium prausnitzii.

Sokol H, Langella P.

Inflamm Bowel Dis. 2014 Jul;20(7):E18. doi: 10.1097/MIB.0000000000000071. No abstract available.

PMID:
24859301
[PubMed - in process]
2.

Complications and surgery in the inflammatory bowel diseases biological era.

Sokol H, Seksik P, Cosnes J.

Curr Opin Gastroenterol. 2014 Jul;30(4):378-84. doi: 10.1097/MOG.0000000000000078.

PMID:
24840000
[PubMed - in process]
3.

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.

Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E, Allez M, Mary JY, Sokol H, Colombel JF, Seksik P.

Inflamm Bowel Dis. 2014 Jun;20(6):978-86. doi: 10.1097/MIB.0000000000000036.

PMID:
24788220
[PubMed - in process]
4.

Letter: not the end of the role of anti-viral therapy in ulcerative colitis with cytomegalovirus reactivation - authors' reply.

Delvincourt M, Sokol H.

Aliment Pharmacol Ther. 2014 May;39(10):1247-8. doi: 10.1111/apt.12722. No abstract available.

PMID:
24735149
[PubMed - in process]
5.

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG.

Hum Vaccin Immunother. 2014 Apr 14;10(6). [Epub ahead of print]

PMID:
24732667
[PubMed - as supplied by publisher]
6.

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F.

PLoS Biol. 2014 Apr 8;12(4):e1001833. doi: 10.1371/journal.pbio.1001833. eCollection 2014 Apr.

PMID:
24714093
[PubMed - in process]
Free PMC Article
7.

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Gut Microbes. 2014 Mar 1;5(2):146-151. Epub 2014 Jan 22. Review.

PMID:
24637606
[PubMed - as supplied by publisher]
8.

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H.

Aliment Pharmacol Ther. 2014 Apr;39(7):712-20. doi: 10.1111/apt.12650. Epub 2014 Feb 9.

PMID:
24506221
[PubMed - in process]
9.

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease.

Rajca S, Seksik P, Bourrier A, Sokol H, Nion-Larmurier I, Beaugerie L, Cosnes J.

J Crohns Colitis. 2014 Aug 1;8(8):819-24. doi: 10.1016/j.crohns.2013.12.022. Epub 2014 Jan 16.

PMID:
24439392
[PubMed - in process]
10.

Bacterial protein signals are associated with Crohn's disease.

Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, Mondot S, Sykacek P, Sokol H, Blon F, Lepercq P, Levenez F, Valot B, Carré W, Loux V, Pons N, David O, Schaeffer B, Lepage P, Martin P, Monnet V, Seksik P, Beaugerie L, Ehrlich SD, Gibrat JF, Van Dorsselaer A, Doré J.

Gut. 2014 Jan 16. doi: 10.1136/gutjnl-2012-303786. [Epub ahead of print]

PMID:
24436141
[PubMed - as supplied by publisher]
Free Article
11.

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P.

Inflamm Bowel Dis. 2014 Mar;20(3):417-30. doi: 10.1097/01.MIB.0000440815.76627.64.

PMID:
24418903
[PubMed - in process]
12.

[A colourful villous atrophy].

Augustin J, Hoyeau N, Sokol H, Fléjou JF, Svrcek M.

Ann Pathol. 2013 Dec;33(6):418-20. doi: 10.1016/j.annpat.2013.10.019. Epub 2013 Nov 21. French. No abstract available.

PMID:
24331726
[PubMed - in process]
13.

Crohn's disease of the vulva.

Barret M, de Parades V, Battistella M, Sokol H, Lemarchand N, Marteau P.

J Crohns Colitis. 2014 Jul 1;8(7):563-70. doi: 10.1016/j.crohns.2013.10.009. Epub 2013 Nov 16.

PMID:
24252167
[PubMed - in process]
14.

Impact of probiotics on risk factors for cardiovascular diseases. A review.

Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P, Gervais P.

Crit Rev Food Sci Nutr. 2014;54(2):175-89. doi: 10.1080/10408398.2011.579361. Review.

PMID:
24188267
[PubMed - indexed for MEDLINE]
15.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; for the CESAME Study Group.

Gut. 2013 Oct 25. doi: 10.1136/gutjnl-2013-305763. [Epub ahead of print]

PMID:
24162591
[PubMed - as supplied by publisher]
16.

[Causes and differential diagnosis of flush].

Lafont E, Sokol H, Sarre-Annweiler ME, Lecornet-Sokol E, Barete S, Hermine O, Pouchot J, Georgin-Lavialle S.

Rev Med Interne. 2014 May;35(5):303-9. doi: 10.1016/j.revmed.2013.08.015. Epub 2013 Sep 27. French.

PMID:
24080240
[PubMed - in process]
Free Article
17.

Gastrointestinal manifestations in mastocytosis: a study of 83 patients.

Sokol H, Georgin-Lavialle S, Canioni D, Barete S, Damaj G, Soucie E, Bruneau J, Chandesris MO, Suarez F, Launay JM, Aouba A, Grandpeix-Guyodo C, Lanternier F, Grosbois B, de Gennes C, Cathébras P, Fain O, Hoyeau-Idrissi N, Dubreuil P, Lortholary O, Beaugerie L, Ranque B, Hermine O.

J Allergy Clin Immunol. 2013 Oct;132(4):866-73.e1-3. doi: 10.1016/j.jaci.2013.05.026. Epub 2013 Jul 26.

PMID:
23890756
[PubMed - indexed for MEDLINE]
18.

Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease.

Rahier JF, Dubuquoy L, Colombel JF, Jouret-Mourin A, Delos M, Ferrante M, Sokol H, Hertogh GD, Salleron J, Geboes K, Desreumaux P.

Inflamm Bowel Dis. 2013 Sep;19(10):2084-90. doi: 10.1097/MIB.0b013e3182971cec.

PMID:
23851640
[PubMed - indexed for MEDLINE]
19.

Faecalibacterium prausnitzii and human intestinal health.

Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P.

Curr Opin Microbiol. 2013 Jun;16(3):255-61. doi: 10.1016/j.mib.2013.06.003. Epub 2013 Jul 3. Review.

PMID:
23831042
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.

Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, Godeberge P, Sokol H, Catherinot E, Poiree S, Chapdelaine H, Dunogue B, Bodemer C, Lecuit M, Fischer A, Lortholary O, Hermine O.

J Allergy Clin Immunol. 2013 Oct;132(4):997-1000.e1-4. doi: 10.1016/j.jaci.2013.04.059. Epub 2013 Jun 20. No abstract available.

PMID:
23791514
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk